C8 Galactosylceramide (d18:1/8:0)

Mfr.No.	T36323
Description	C8 Galactosylceramide is a synthetic C8 short-chain derivative of known membrane microdomain-forming sphingolipids. It increases the amount delivered and toxicity of doxorubicin in cancerous but not non-cancerous cells when incorporated into the nanoliposomal membrane of nanoliposomal-doxorubicin. C8 Galactosylceramide induces proliferation and cytokine production by splenocytes in vitro at concentrations ranging from 100-1,000 ng/ml but has no effect on natural killer T cell production in vivo. It also activates NF-kappaB production in C6 glioma cells when used at a concentration of 10 uM.
Molecular Formula	C32H61NO8
Signaling Pathways	Others
Smiles	O(C(CH)(NC(CCCCCCC)=O)(CH)(/C=C/CCCCCCCCCCCCC)O)(CH)1O(CH)(CO)(CH)(O)(CH)(O)(CH)1O
Cas Number	41613-16-5
Molecular Weight	587.83
Target	Others

Have you used this product?

SKU	Supplier No.	Size	Your price	Quantity
BHB20425643	T36323	10 mg	$777		Add to Cart